

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 4.64629961 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.64629961 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.30424275 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.28939972 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.18786727 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 4.05722446 |
| 7 | modulation by symbiont of host defense response (GO:0052031) | 4.05722446 |
| 8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.05722446 |
| 9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.05722446 |
| 10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.05722446 |
| 11 | modulation by symbiont of host immune response (GO:0052553) | 4.05722446 |
| 12 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.04661409 |
| 13 | L-fucose catabolic process (GO:0042355) | 4.03062725 |
| 14 | fucose catabolic process (GO:0019317) | 4.03062725 |
| 15 | L-fucose metabolic process (GO:0042354) | 4.03062725 |
| 16 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.03011980 |
| 17 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.83778926 |
| 18 | microglial cell activation (GO:0001774) | 3.62416651 |
| 19 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.55650677 |
| 20 | negative regulation of interleukin-12 production (GO:0032695) | 3.51258250 |
| 21 | activated T cell proliferation (GO:0050798) | 3.51179262 |
| 22 | negative regulation of interleukin-1 production (GO:0032692) | 3.50161375 |
| 23 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.49712515 |
| 24 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.45655275 |
| 25 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.35594989 |
| 26 | neutrophil mediated immunity (GO:0002446) | 3.33388600 |
| 27 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.28771799 |
| 28 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.26840262 |
| 29 | neural tube formation (GO:0001841) | 3.24342720 |
| 30 | macrophage activation involved in immune response (GO:0002281) | 3.21774602 |
| 31 | tolerance induction (GO:0002507) | 3.16540210 |
| 32 | neutrophil activation involved in immune response (GO:0002283) | 3.14798362 |
| 33 | superoxide anion generation (GO:0042554) | 3.13052446 |
| 34 | cellular extravasation (GO:0045123) | 3.11035021 |
| 35 | regulation of gamma-delta T cell activation (GO:0046643) | 3.10494724 |
| 36 | negative T cell selection (GO:0043383) | 3.10379156 |
| 37 | negative thymic T cell selection (GO:0045060) | 3.06323790 |
| 38 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.05438813 |
| 39 | neutrophil activation (GO:0042119) | 3.04232465 |
| 40 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.02537050 |
| 41 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 3.02082025 |
| 42 | cellular response to interleukin-15 (GO:0071350) | 3.01270127 |
| 43 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.00354155 |
| 44 | DNA deamination (GO:0045006) | 2.99810610 |
| 45 | leukocyte aggregation (GO:0070486) | 2.99087583 |
| 46 | negative regulation of T cell mediated immunity (GO:0002710) | 2.97177064 |
| 47 | myeloid leukocyte mediated immunity (GO:0002444) | 2.94319860 |
| 48 | response to host immune response (GO:0052572) | 2.92918517 |
| 49 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.92918517 |
| 50 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.90227497 |
| 51 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.89249752 |
| 52 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.89249752 |
| 53 | macrophage activation (GO:0042116) | 2.87121126 |
| 54 | epithelial cilium movement (GO:0003351) | 2.86963165 |
| 55 | interferon-gamma secretion (GO:0072643) | 2.83638909 |
| 56 | response to interleukin-15 (GO:0070672) | 2.83052296 |
| 57 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.82190814 |
| 58 | regulation of interferon-alpha production (GO:0032647) | 2.80455373 |
| 59 | negative regulation of interleukin-6 production (GO:0032715) | 2.79903020 |
| 60 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.79359073 |
| 61 | immunoglobulin mediated immune response (GO:0016064) | 2.79354987 |
| 62 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.78924312 |
| 63 | negative regulation of B cell mediated immunity (GO:0002713) | 2.78924312 |
| 64 | detection of other organism (GO:0098543) | 2.78039904 |
| 65 | response to type I interferon (GO:0034340) | 2.78020313 |
| 66 | positive regulation of interferon-alpha production (GO:0032727) | 2.77453435 |
| 67 | respiratory burst (GO:0045730) | 2.75648737 |
| 68 | positive regulation of mast cell activation (GO:0033005) | 2.75429375 |
| 69 | response to peptidoglycan (GO:0032494) | 2.73765279 |
| 70 | B cell receptor signaling pathway (GO:0050853) | 2.70002683 |
| 71 | regulation of memory T cell differentiation (GO:0043380) | 2.69925314 |
| 72 | negative regulation of adaptive immune response (GO:0002820) | 2.69645725 |
| 73 | germinal center formation (GO:0002467) | 2.68945145 |
| 74 | type I interferon signaling pathway (GO:0060337) | 2.68920129 |
| 75 | cellular response to type I interferon (GO:0071357) | 2.68920129 |
| 76 | regulation of mast cell activation (GO:0033003) | 2.67579597 |
| 77 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.67569445 |
| 78 | positive regulation of antigen processing and presentation (GO:0002579) | 2.66632419 |
| 79 | cilium movement (GO:0003341) | 2.65391926 |
| 80 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.64129791 |
| 81 | granulocyte activation (GO:0036230) | 2.63019052 |
| 82 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.61869770 |
| 83 | positive regulation of defense response to virus by host (GO:0002230) | 2.60672947 |
| 84 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.59490857 |
| 85 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.59060942 |
| 86 | positive regulation of interferon-beta production (GO:0032728) | 2.58601064 |
| 87 | dendritic cell migration (GO:0036336) | 2.55040946 |
| 88 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.54424324 |
| 89 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.54414762 |
| 90 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.54257572 |
| 91 | detection of bacterium (GO:0016045) | 2.53810767 |
| 92 | defense response to protozoan (GO:0042832) | 2.52005354 |
| 93 | interferon-gamma production (GO:0032609) | 2.51990369 |
| 94 | myeloid cell activation involved in immune response (GO:0002275) | 2.51776535 |
| 95 | response to host (GO:0075136) | 2.51290630 |
| 96 | response to host defenses (GO:0052200) | 2.51290630 |
| 97 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.51290630 |
| 98 | regulation of B cell apoptotic process (GO:0002902) | 2.51269108 |
| 99 | cellular response to exogenous dsRNA (GO:0071360) | 2.50504298 |
| 100 | positive regulation of granulocyte differentiation (GO:0030854) | 2.49663841 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.14654252 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.65821156 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.05441448 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.98519481 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.84856923 |
| 6 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.84180498 |
| 7 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.82646995 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.65570452 |
| 9 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.38975697 |
| 10 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.17153142 |
| 11 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.10367384 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.08212435 |
| 13 | MYB_26560356_Chip-Seq_TH2_Human | 1.97226759 |
| 14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.96797013 |
| 15 | GATA3_26560356_Chip-Seq_TH2_Human | 1.92051416 |
| 16 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.82360209 |
| 17 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.80235090 |
| 18 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.70098293 |
| 19 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.67492891 |
| 20 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.66499871 |
| 21 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.64486775 |
| 22 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.64152303 |
| 23 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.62308646 |
| 24 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.62059570 |
| 25 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.61081994 |
| 26 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.60247419 |
| 27 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.59386152 |
| 28 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.58359240 |
| 29 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.48341555 |
| 30 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.44390172 |
| 31 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.41855316 |
| 32 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.40874690 |
| 33 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.39252077 |
| 34 | * MYB_26560356_Chip-Seq_TH1_Human | 1.39172326 |
| 35 | EWS_26573619_Chip-Seq_HEK293_Human | 1.38190963 |
| 36 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.30178354 |
| 37 | VDR_22108803_ChIP-Seq_LS180_Human | 1.30076682 |
| 38 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28463736 |
| 39 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.25475473 |
| 40 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.23250220 |
| 41 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22269789 |
| 42 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21837530 |
| 43 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.21837530 |
| 44 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.21506477 |
| 45 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21097526 |
| 46 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.20964951 |
| 47 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.20788310 |
| 48 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19505160 |
| 49 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.19384038 |
| 50 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.19293234 |
| 51 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.18782230 |
| 52 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.18244270 |
| 53 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.15611229 |
| 54 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.15600538 |
| 55 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.15585058 |
| 56 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.14733368 |
| 57 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14440691 |
| 58 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.14267175 |
| 59 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.13744096 |
| 60 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.13182274 |
| 61 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.11314990 |
| 62 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.11069047 |
| 63 | STAT3_23295773_ChIP-Seq_U87_Human | 1.10405343 |
| 64 | SPI1_23127762_ChIP-Seq_K562_Human | 1.09050649 |
| 65 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.08167445 |
| 66 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.08077133 |
| 67 | GATA3_26560356_Chip-Seq_TH1_Human | 1.05812124 |
| 68 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.05335249 |
| 69 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04705270 |
| 70 | P300_19829295_ChIP-Seq_ESCs_Human | 1.04561499 |
| 71 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04468167 |
| 72 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.03448229 |
| 73 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.02666124 |
| 74 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.00527762 |
| 75 | FUS_26573619_Chip-Seq_HEK293_Human | 0.99619591 |
| 76 | TCF4_23295773_ChIP-Seq_U87_Human | 0.98916452 |
| 77 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.98725929 |
| 78 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.98061623 |
| 79 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97753949 |
| 80 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.97517550 |
| 81 | AR_20517297_ChIP-Seq_VCAP_Human | 0.97475320 |
| 82 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96709419 |
| 83 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.94888128 |
| 84 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.94879780 |
| 85 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.93610635 |
| 86 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.92493913 |
| 87 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.92493913 |
| 88 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.91308403 |
| 89 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.89699766 |
| 90 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89011636 |
| 91 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.88534406 |
| 92 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.87431508 |
| 93 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.87431508 |
| 94 | * HOXB7_26014856_ChIP-Seq_BT474_Human | 0.87184192 |
| 95 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.87002450 |
| 96 | * MAF_26560356_Chip-Seq_TH1_Human | 0.84488380 |
| 97 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.84176103 |
| 98 | NCOR_22424771_ChIP-Seq_293T_Human | 0.83813689 |
| 99 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.83228174 |
| 100 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.82986739 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 3.93682865 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.03894900 |
| 3 | MP0001800_abnormal_humoral_immune | 2.59807258 |
| 4 | MP0000569_abnormal_digit_pigmentation | 2.52913945 |
| 5 | MP0000685_abnormal_immune_system | 2.47813858 |
| 6 | MP0005671_abnormal_response_to | 2.45797040 |
| 7 | MP0003436_decreased_susceptibility_to | 2.40511977 |
| 8 | MP0003195_calcinosis | 2.37106645 |
| 9 | MP0001790_abnormal_immune_system | 2.33293392 |
| 10 | MP0005387_immune_system_phenotype | 2.33293392 |
| 11 | MP0003303_peritoneal_inflammation | 2.32192188 |
| 12 | MP0002277_abnormal_respiratory_mucosa | 2.14741825 |
| 13 | MP0002723_abnormal_immune_serum | 2.13205278 |
| 14 | MP0001986_abnormal_taste_sensitivity | 2.05239601 |
| 15 | MP0005000_abnormal_immune_tolerance | 2.05073036 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.04953294 |
| 17 | MP0002419_abnormal_innate_immunity | 2.03485115 |
| 18 | MP0009785_altered_susceptibility_to | 2.02682027 |
| 19 | MP0002420_abnormal_adaptive_immunity | 1.99402569 |
| 20 | MP0003763_abnormal_thymus_physiology | 1.99130096 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 1.98715249 |
| 22 | MP0008877_abnormal_DNA_methylation | 1.98465491 |
| 23 | MP0002653_abnormal_ependyma_morphology | 1.97778895 |
| 24 | MP0001819_abnormal_immune_cell | 1.97398005 |
| 25 | MP0005025_abnormal_response_to | 1.91373605 |
| 26 | MP0002102_abnormal_ear_morphology | 1.81660074 |
| 27 | MP0005174_abnormal_tail_pigmentation | 1.81335826 |
| 28 | MP0009764_decreased_sensitivity_to | 1.77463746 |
| 29 | MP0004043_abnormal_pH_regulation | 1.70924544 |
| 30 | MP0005310_abnormal_salivary_gland | 1.65545306 |
| 31 | MP0002405_respiratory_system_inflammati | 1.63921472 |
| 32 | MP0002138_abnormal_hepatobiliary_system | 1.63019353 |
| 33 | MP0004381_abnormal_hair_follicle | 1.61750730 |
| 34 | MP0002928_abnormal_bile_duct | 1.58670434 |
| 35 | MP0003787_abnormal_imprinting | 1.54370745 |
| 36 | MP0005075_abnormal_melanosome_morpholog | 1.52283256 |
| 37 | MP0000716_abnormal_immune_system | 1.51115569 |
| 38 | MP0000427_abnormal_hair_cycle | 1.47904363 |
| 39 | MP0003646_muscle_fatigue | 1.47398018 |
| 40 | MP0000015_abnormal_ear_pigmentation | 1.44370513 |
| 41 | MP0002398_abnormal_bone_marrow | 1.43618063 |
| 42 | MP0008057_abnormal_DNA_replication | 1.42365285 |
| 43 | MP0000689_abnormal_spleen_morphology | 1.41493969 |
| 44 | MP0003300_gastrointestinal_ulcer | 1.40075850 |
| 45 | MP0001845_abnormal_inflammatory_respons | 1.36523377 |
| 46 | MP0006082_CNS_inflammation | 1.34793396 |
| 47 | MP0000372_irregular_coat_pigmentation | 1.33860345 |
| 48 | MP0009278_abnormal_bone_marrow | 1.27048516 |
| 49 | MP0003866_abnormal_defecation | 1.26454710 |
| 50 | MP0001533_abnormal_skeleton_physiology | 1.25498506 |
| 51 | MP0010155_abnormal_intestine_physiology | 1.25371745 |
| 52 | MP0002132_abnormal_respiratory_system | 1.25220010 |
| 53 | MP0002722_abnormal_immune_system | 1.22787594 |
| 54 | MP0002876_abnormal_thyroid_physiology | 1.22622772 |
| 55 | MP0000703_abnormal_thymus_morphology | 1.21686474 |
| 56 | MP0005253_abnormal_eye_physiology | 1.21583859 |
| 57 | MP0004883_abnormal_blood_vessel | 1.17966794 |
| 58 | MP0005551_abnormal_eye_electrophysiolog | 1.15987402 |
| 59 | MP0001501_abnormal_sleep_pattern | 1.10543452 |
| 60 | MP0003183_abnormal_peptide_metabolism | 1.09887792 |
| 61 | MP0000383_abnormal_hair_follicle | 1.09813666 |
| 62 | MP0002429_abnormal_blood_cell | 1.08011909 |
| 63 | MP0002166_altered_tumor_susceptibility | 1.07879899 |
| 64 | MP0001873_stomach_inflammation | 1.07547436 |
| 65 | MP0002163_abnormal_gland_morphology | 1.06575406 |
| 66 | MP0008872_abnormal_physiological_respon | 1.02002341 |
| 67 | MP0005397_hematopoietic_system_phenotyp | 1.00212930 |
| 68 | MP0001545_abnormal_hematopoietic_system | 1.00212930 |
| 69 | MP0003172_abnormal_lysosome_physiology | 0.98480265 |
| 70 | MP0002095_abnormal_skin_pigmentation | 0.98314645 |
| 71 | MP0002009_preneoplasia | 0.92705458 |
| 72 | MP0003011_delayed_dark_adaptation | 0.91313777 |
| 73 | MP0008469_abnormal_protein_level | 0.90510964 |
| 74 | MP0001968_abnormal_touch/_nociception | 0.89934814 |
| 75 | MP0001485_abnormal_pinna_reflex | 0.89407463 |
| 76 | MP0004742_abnormal_vestibular_system | 0.88298942 |
| 77 | MP0002396_abnormal_hematopoietic_system | 0.88159944 |
| 78 | MP0003252_abnormal_bile_duct | 0.88157807 |
| 79 | MP0003656_abnormal_erythrocyte_physiolo | 0.88151905 |
| 80 | MP0000371_diluted_coat_color | 0.87870546 |
| 81 | MP0008961_abnormal_basal_metabolism | 0.87614205 |
| 82 | MP0004947_skin_inflammation | 0.86400355 |
| 83 | MP0002693_abnormal_pancreas_physiology | 0.85730544 |
| 84 | MP0003045_fibrosis | 0.80168594 |
| 85 | MP0001663_abnormal_digestive_system | 0.80016239 |
| 86 | MP0004142_abnormal_muscle_tone | 0.79573224 |
| 87 | MP0005266_abnormal_metabolism | 0.78850787 |
| 88 | MP0002638_abnormal_pupillary_reflex | 0.78314826 |
| 89 | MP0000470_abnormal_stomach_morphology | 0.76516056 |
| 90 | MP0002332_abnormal_exercise_endurance | 0.74299520 |
| 91 | MP0004808_abnormal_hematopoietic_stem | 0.73575359 |
| 92 | MP0002837_dystrophic_cardiac_calcinosis | 0.71984054 |
| 93 | MP0002006_tumorigenesis | 0.70774696 |
| 94 | MP0003878_abnormal_ear_physiology | 0.68963878 |
| 95 | MP0005377_hearing/vestibular/ear_phenot | 0.68963878 |
| 96 | MP0009765_abnormal_xenobiotic_induced | 0.66257430 |
| 97 | MP0009745_abnormal_behavioral_response | 0.64451251 |
| 98 | MP0004484_altered_response_of | 0.63781134 |
| 99 | MP0000631_abnormal_neuroendocrine_gland | 0.63550535 |
| 100 | MP0009046_muscle_twitch | 0.63469972 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stomatitis (HP:0010280) | 4.01217570 |
| 2 | Pancreatic cysts (HP:0001737) | 3.96003981 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 3.67746962 |
| 4 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.53115736 |
| 5 | Pancreatic fibrosis (HP:0100732) | 3.49310809 |
| 6 | Optic neuritis (HP:0100653) | 3.45072811 |
| 7 | Retrobulbar optic neuritis (HP:0100654) | 3.45072811 |
| 8 | Myositis (HP:0100614) | 3.41206385 |
| 9 | Recurrent abscess formation (HP:0002722) | 3.33661524 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.26514003 |
| 11 | Orchitis (HP:0100796) | 3.21837813 |
| 12 | Recurrent fungal infections (HP:0002841) | 3.18466702 |
| 13 | Eczematoid dermatitis (HP:0000976) | 3.17648518 |
| 14 | True hermaphroditism (HP:0010459) | 3.14848166 |
| 15 | Absent/shortened dynein arms (HP:0200106) | 2.98538032 |
| 16 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.98538032 |
| 17 | Panhypogammaglobulinemia (HP:0003139) | 2.98255881 |
| 18 | Congenital stationary night blindness (HP:0007642) | 2.97511105 |
| 19 | Attenuation of retinal blood vessels (HP:0007843) | 2.91159011 |
| 20 | Abnormality of midbrain morphology (HP:0002418) | 2.89679519 |
| 21 | Molar tooth sign on MRI (HP:0002419) | 2.89679519 |
| 22 | Recurrent cutaneous fungal infections (HP:0011370) | 2.79761340 |
| 23 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.79761340 |
| 24 | Nephronophthisis (HP:0000090) | 2.78950778 |
| 25 | Stomach cancer (HP:0012126) | 2.69213244 |
| 26 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.66621191 |
| 27 | Recurrent skin infections (HP:0001581) | 2.64048460 |
| 28 | Encephalitis (HP:0002383) | 2.58830456 |
| 29 | Abnormality of the renal medulla (HP:0100957) | 2.58458128 |
| 30 | Cystic liver disease (HP:0006706) | 2.55508917 |
| 31 | Chronic otitis media (HP:0000389) | 2.55242109 |
| 32 | Hyperventilation (HP:0002883) | 2.55100345 |
| 33 | Abnormality of T cell number (HP:0011839) | 2.52087204 |
| 34 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.50587741 |
| 35 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.50587741 |
| 36 | T lymphocytopenia (HP:0005403) | 2.49228793 |
| 37 | Chronic hepatic failure (HP:0100626) | 2.47542169 |
| 38 | Abnormal ciliary motility (HP:0012262) | 2.42659368 |
| 39 | Abnormality of the renal cortex (HP:0011035) | 2.41041155 |
| 40 | Hypochromic microcytic anemia (HP:0004840) | 2.40967673 |
| 41 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.38660004 |
| 42 | Agitation (HP:0000713) | 2.32624825 |
| 43 | Keratoconjunctivitis (HP:0001096) | 2.32390680 |
| 44 | Tubular atrophy (HP:0000092) | 2.26719058 |
| 45 | Abnormality of T cells (HP:0002843) | 2.24090727 |
| 46 | Abnormal drinking behavior (HP:0030082) | 2.23476102 |
| 47 | Polydipsia (HP:0001959) | 2.23476102 |
| 48 | Medial flaring of the eyebrow (HP:0010747) | 2.23470935 |
| 49 | Meningitis (HP:0001287) | 2.20068572 |
| 50 | Keratoconjunctivitis sicca (HP:0001097) | 2.19004317 |
| 51 | Abnormality of macrophages (HP:0004311) | 2.18734433 |
| 52 | Progressive inability to walk (HP:0002505) | 2.15900226 |
| 53 | Type II lissencephaly (HP:0007260) | 2.13278404 |
| 54 | Mediastinal lymphadenopathy (HP:0100721) | 2.12955935 |
| 55 | Absent speech (HP:0001344) | 2.12334956 |
| 56 | Genetic anticipation (HP:0003743) | 2.11865470 |
| 57 | Abolished electroretinogram (ERG) (HP:0000550) | 2.11758681 |
| 58 | Spontaneous hematomas (HP:0007420) | 2.10109915 |
| 59 | Gastrointestinal infarctions (HP:0005244) | 2.08504308 |
| 60 | Abnormality of T cell physiology (HP:0011840) | 2.08039682 |
| 61 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.07038701 |
| 62 | Furrowed tongue (HP:0000221) | 2.06887391 |
| 63 | Gaze-evoked nystagmus (HP:0000640) | 2.05736880 |
| 64 | Hemoptysis (HP:0002105) | 2.00150370 |
| 65 | Thyroiditis (HP:0100646) | 1.99545284 |
| 66 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.98730986 |
| 67 | Lissencephaly (HP:0001339) | 1.98701280 |
| 68 | Hematochezia (HP:0002573) | 1.98194628 |
| 69 | Decreased circulating renin level (HP:0003351) | 1.97409079 |
| 70 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.97206405 |
| 71 | Asplenia (HP:0001746) | 1.97205648 |
| 72 | Hypochromic anemia (HP:0001931) | 1.96920596 |
| 73 | Hip dysplasia (HP:0001385) | 1.94656524 |
| 74 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.94157312 |
| 75 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.88694593 |
| 76 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.88616656 |
| 77 | Vasculitis (HP:0002633) | 1.88123348 |
| 78 | Abnormal biliary tract physiology (HP:0012439) | 1.87807396 |
| 79 | Bile duct proliferation (HP:0001408) | 1.87807396 |
| 80 | IgG deficiency (HP:0004315) | 1.87149873 |
| 81 | Decreased central vision (HP:0007663) | 1.86813855 |
| 82 | Congenital hepatic fibrosis (HP:0002612) | 1.86794039 |
| 83 | Eosinophilia (HP:0001880) | 1.86717267 |
| 84 | Leukocytosis (HP:0001974) | 1.85957888 |
| 85 | Pendular nystagmus (HP:0012043) | 1.85826260 |
| 86 | Recurrent viral infections (HP:0004429) | 1.85186699 |
| 87 | Bronchiectasis (HP:0002110) | 1.83387170 |
| 88 | Prostate neoplasm (HP:0100787) | 1.82146344 |
| 89 | Clumsiness (HP:0002312) | 1.81221223 |
| 90 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.80962292 |
| 91 | Inability to walk (HP:0002540) | 1.80677867 |
| 92 | Anencephaly (HP:0002323) | 1.80528489 |
| 93 | Recurrent sinusitis (HP:0011108) | 1.80497502 |
| 94 | Nephrogenic diabetes insipidus (HP:0009806) | 1.80044107 |
| 95 | Chronic diarrhea (HP:0002028) | 1.78567133 |
| 96 | Abnormality of eosinophils (HP:0001879) | 1.77931539 |
| 97 | Pulmonary infiltrates (HP:0002113) | 1.77378729 |
| 98 | Congenital sensorineural hearing impairment (HP:0008527) | 1.77365621 |
| 99 | Rhinitis (HP:0012384) | 1.76596885 |
| 100 | Increased cerebral lipofuscin (HP:0011813) | 1.76577823 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 5.47441107 |
| 2 | ACVR1B | 3.25005873 |
| 3 | BLK | 2.74227721 |
| 4 | BMPR1B | 2.70521779 |
| 5 | TAOK3 | 2.44504993 |
| 6 | MAP4K1 | 2.41599649 |
| 7 | RIPK4 | 2.27963903 |
| 8 | TXK | 2.13483749 |
| 9 | IRAK4 | 2.08187247 |
| 10 | DAPK2 | 2.02493876 |
| 11 | GRK6 | 1.90594311 |
| 12 | TNK2 | 1.87180830 |
| 13 | ADRBK2 | 1.82795273 |
| 14 | IKBKE | 1.78958801 |
| 15 | IRAK1 | 1.69621881 |
| 16 | WNK3 | 1.68659986 |
| 17 | CAMKK2 | 1.65327430 |
| 18 | IKBKB | 1.51125642 |
| 19 | TYK2 | 1.45039433 |
| 20 | BTK | 1.40324275 |
| 21 | SYK | 1.39800428 |
| 22 | GRK1 | 1.35966054 |
| 23 | MAP4K2 | 1.35852117 |
| 24 | CSK | 1.35005372 |
| 25 | TLK1 | 1.32875551 |
| 26 | FES | 1.30844372 |
| 27 | NLK | 1.28481364 |
| 28 | TEC | 1.24371644 |
| 29 | MAP2K6 | 1.23273162 |
| 30 | EPHA3 | 1.16301268 |
| 31 | MAPK13 | 1.16144019 |
| 32 | LYN | 1.15355884 |
| 33 | HCK | 1.12769138 |
| 34 | PRKD2 | 1.11272055 |
| 35 | TRIM28 | 1.08975527 |
| 36 | ITK | 1.08833348 |
| 37 | MARK3 | 1.07441584 |
| 38 | MAP2K3 | 1.07076411 |
| 39 | MAP3K14 | 1.06315009 |
| 40 | PTK2B | 1.05347621 |
| 41 | INSRR | 1.03911577 |
| 42 | OXSR1 | 1.01318946 |
| 43 | NUAK1 | 1.00841997 |
| 44 | JAK3 | 1.00483067 |
| 45 | MAP3K4 | 0.98049035 |
| 46 | JAK1 | 0.93304530 |
| 47 | TAOK1 | 0.93290599 |
| 48 | JAK2 | 0.92648082 |
| 49 | MAP3K7 | 0.91017408 |
| 50 | CHUK | 0.89393474 |
| 51 | ADRBK1 | 0.85240392 |
| 52 | TGFBR1 | 0.85070038 |
| 53 | ZAP70 | 0.84977627 |
| 54 | FGR | 0.84189131 |
| 55 | LCK | 0.83714494 |
| 56 | KIT | 0.79245204 |
| 57 | CAMK1D | 0.77988581 |
| 58 | MAPKAPK3 | 0.77930011 |
| 59 | STK11 | 0.77333608 |
| 60 | PAK3 | 0.75504306 |
| 61 | TBK1 | 0.74223426 |
| 62 | YES1 | 0.73801721 |
| 63 | PRKCQ | 0.72157951 |
| 64 | FGFR2 | 0.71836379 |
| 65 | EPHB1 | 0.71382881 |
| 66 | CAMKK1 | 0.68458843 |
| 67 | CSF1R | 0.66591681 |
| 68 | ZAK | 0.66530532 |
| 69 | MAPK15 | 0.65620295 |
| 70 | CAMK4 | 0.65041236 |
| 71 | SGK2 | 0.63924691 |
| 72 | STK38 | 0.61847102 |
| 73 | HIPK2 | 0.61122652 |
| 74 | STK10 | 0.58831182 |
| 75 | BRSK2 | 0.53301992 |
| 76 | BRD4 | 0.52832560 |
| 77 | SIK2 | 0.50549222 |
| 78 | MELK | 0.49993776 |
| 79 | TRPM7 | 0.49674209 |
| 80 | PIM1 | 0.49530801 |
| 81 | RPS6KA6 | 0.48607363 |
| 82 | MAP2K4 | 0.48243560 |
| 83 | PDK1 | 0.48117753 |
| 84 | CSNK1A1L | 0.46859829 |
| 85 | RPS6KA5 | 0.46782456 |
| 86 | MKNK2 | 0.45408465 |
| 87 | MAP2K2 | 0.44750090 |
| 88 | GRK7 | 0.44541300 |
| 89 | PIK3CG | 0.43435999 |
| 90 | CSNK1G3 | 0.41619178 |
| 91 | PRKCZ | 0.40714314 |
| 92 | CDK19 | 0.39722965 |
| 93 | PINK1 | 0.37436368 |
| 94 | PRKAA2 | 0.36255573 |
| 95 | CSNK1G1 | 0.36071116 |
| 96 | CASK | 0.35750635 |
| 97 | MAPK11 | 0.33910385 |
| 98 | CSNK1G2 | 0.33533537 |
| 99 | SGK3 | 0.32886051 |
| 100 | PRKCH | 0.32670287 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.62183613 |
| 2 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.29183980 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.17379193 |
| 4 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.14073518 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.11556580 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.10859500 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.08603089 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.07955293 |
| 9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.04513927 |
| 10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.96696595 |
| 11 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.90452107 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.87677611 |
| 13 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.84686101 |
| 14 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.73625521 |
| 15 | Tuberculosis_Homo sapiens_hsa05152 | 1.70195460 |
| 16 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.66516404 |
| 17 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.64999763 |
| 18 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.59728041 |
| 19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.56803214 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.55627537 |
| 21 | Asthma_Homo sapiens_hsa05310 | 1.52351963 |
| 22 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.52296722 |
| 23 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.51314583 |
| 24 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.50810683 |
| 25 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.46848639 |
| 26 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.46654197 |
| 27 | Measles_Homo sapiens_hsa05162 | 1.46638500 |
| 28 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.36397991 |
| 29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.33740311 |
| 30 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.32309457 |
| 31 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.30919860 |
| 32 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.30141316 |
| 33 | Legionellosis_Homo sapiens_hsa05134 | 1.27652888 |
| 34 | Phototransduction_Homo sapiens_hsa04744 | 1.24598128 |
| 35 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.22606791 |
| 36 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.18976230 |
| 37 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.16799435 |
| 38 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.16616368 |
| 39 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.16166268 |
| 40 | Influenza A_Homo sapiens_hsa05164 | 1.14573194 |
| 41 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.11678102 |
| 42 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.11658922 |
| 43 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.09241694 |
| 44 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.07989070 |
| 45 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.03280133 |
| 46 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.02677537 |
| 47 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.01158309 |
| 48 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.00854333 |
| 49 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.00201260 |
| 50 | ABC transporters_Homo sapiens_hsa02010 | 0.98686872 |
| 51 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.94617906 |
| 52 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.93995604 |
| 53 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.90911931 |
| 54 | Homologous recombination_Homo sapiens_hsa03440 | 0.90376019 |
| 55 | Malaria_Homo sapiens_hsa05144 | 0.86415476 |
| 56 | Hepatitis C_Homo sapiens_hsa05160 | 0.86375275 |
| 57 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.84228732 |
| 58 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.81486210 |
| 59 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.80999770 |
| 60 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.80488935 |
| 61 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.80189466 |
| 62 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.78164205 |
| 63 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.77915299 |
| 64 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.76749350 |
| 65 | Hepatitis B_Homo sapiens_hsa05161 | 0.75696352 |
| 66 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.75351932 |
| 67 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.74965579 |
| 68 | Morphine addiction_Homo sapiens_hsa05032 | 0.72198813 |
| 69 | Phagosome_Homo sapiens_hsa04145 | 0.70854382 |
| 70 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.67665467 |
| 71 | Lysosome_Homo sapiens_hsa04142 | 0.65578739 |
| 72 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.65444695 |
| 73 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.65064723 |
| 74 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.59034140 |
| 75 | Basal transcription factors_Homo sapiens_hsa03022 | 0.58209794 |
| 76 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.57221082 |
| 77 | Taste transduction_Homo sapiens_hsa04742 | 0.55341797 |
| 78 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.54590458 |
| 79 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.53099308 |
| 80 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.52335871 |
| 81 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.51124322 |
| 82 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.50964097 |
| 83 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.49719242 |
| 84 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.49702444 |
| 85 | Apoptosis_Homo sapiens_hsa04210 | 0.45913980 |
| 86 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.45688324 |
| 87 | Viral myocarditis_Homo sapiens_hsa05416 | 0.44744036 |
| 88 | Platelet activation_Homo sapiens_hsa04611 | 0.44446294 |
| 89 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.43492829 |
| 90 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.42679715 |
| 91 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.41075422 |
| 92 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.40720263 |
| 93 | Olfactory transduction_Homo sapiens_hsa04740 | 0.38439519 |
| 94 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.38424702 |
| 95 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.35034780 |
| 96 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.34966975 |
| 97 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.30045835 |
| 98 | Pertussis_Homo sapiens_hsa05133 | 0.29785038 |
| 99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.27387191 |
| 100 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.26726406 |

